Studii clinice pentru Migrenă în Nebraska
8 studii pentru Migrenă caută participanți în Nebraska.
Orașe în Nebraska
Text oficial al studiului (în engleză)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital & Medical Center, Omaha
În curs de recrutareFaza 1
Vârste de la 6 la 11 · Toate sexele · Actualizat 28 sept. 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Grand Island, Grand Island
- Papillion Research Center/CCT Research, Papillion
În curs de recrutareFaza 3
Vârste de la 6 la 17 · Toate sexele · Actualizat 28 sept. 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's Hospital & Medical Center, Omaha
În curs de recrutareFaza 3
Vârste de la 6 la 17 · Toate sexele · Actualizat 24 sept. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's Hospital & Medical Center, Omaha
În curs de recrutareFaza 3
Vârste de la 6 la 17 · Toate sexele · Actualizat 24 sept. 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Cct Research - Papillion Research Center /ID# 270393, Papillion
În curs de recrutareFaza 3
Vârste de la 12 la 17 · Toate sexele · Actualizat 22 sept. 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nebraska Medical Center, Omaha
În curs de recrutareFaza 4
Vârste de la 18 la 70 · Toate sexele · Actualizat 16 sept. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Cognitive Clinical Trials (CCT) - Papillion /ID# 232552, Papillion
În curs de recrutareFaza 3
Vârste de la 6 la 17 · Toate sexele · Actualizat 14 sept. 2026 · NCT05125302Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Tri City Research Center, LLC /ID# 278800, Grand Island
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 10 feb. 2026 · NCT07310290Sursă: ClinicalTrials.gov, date preluate la 4 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.